Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Why can’t we break the $0.10?

<< Previous

Bullboard Posts

Next >>

Comment by Eagleeye2468on Feb 18, 2021 10:50am

106 Views

Post# 32595330

RE:Why can’t we break the $0.10?

Common to see that before big moves. The big players hold it back to get placed before big moves upward. Look at the accumulation over the last while and recent volume that makes sense before news etc. This stock has hit .50+ more times then I can count so I could see a 5-10 bagger on positive news

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec